NGM Biopharmaceuticals Inc. is focused on the discovery and development of breakthrough therapeutics for metabolic diseases. NGM has devised a novel discovery platform, relying on human clinical and genetic observations, to identify and validate targets that impact the underlying etiology of disease.
Funding Rounds 1
|15.03.2010||Series B||$51M||-||NGM Biopha...|
Mentions in press and media 3